Related Experiment Video
Updated: Feb 8, 2026

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
Published on: May 10, 2022
[Genetic testing to prevent sudden cardiac death]
B Stallmeyer1, S Dittmann1, E Schulze-Bahr2
1Institut für Genetik von Herzerkrankungen (IfGH), Universitätsklinikum Münster (UKM), Albert-Schweitzer-Campus 1, Gebäude D3, 48129, Münster, Deutschland.
Abstract:
Successfully incorporating genetic testing into clinical practice to prevent sudden cardiac death (SCD) requires (1) appropriate recognition of an inherited cardiovascular condition, (2) identification of appropriate family members at risk and for genetic testing, (3) selection of the appropriate genetic test and information about the expected diagnostic yield, (4) understanding the complexity of result interpretation and distinct handling of incidental findings and (5) providing effective communication and medical advice regarding the genetic and medical results and implications to the patient and his family. Molecular autopsy in SCD victims will be of future importance to determine the cause of death. Interdisciplinary patient care should be provided in specialized centers with a high level of cardiogenetic expertise and is recommended to provide precise and individualized patient management.
Related Concept Videos
Genetics of Speciation
Cancer Prevention
Some...
What is Population Genetics?
What is Genetic Engineering?
Prevention of Further Absorption of Poison
Preventive Healthcare Services

